5TH2
Cetuximab Fab in complex with L5Q meditope variant
Functional Information from PDB Data
| site_id | AC1 |
| Number of Residues | 7 |
| Details | binding site for residue PO4 A 301 |
| Chain | Residue |
| A | GLU165 |
| A | ASP167 |
| A | HOH403 |
| A | HOH408 |
| A | HOH429 |
| A | HOH436 |
| B | HIS170 |
| site_id | AC2 |
| Number of Residues | 2 |
| Details | binding site for residue PO4 B 301 |
| Chain | Residue |
| B | ASN205 |
| B | ASN210 |
| site_id | AC3 |
| Number of Residues | 8 |
| Details | binding site for residue PO4 C 301 |
| Chain | Residue |
| C | GLU165 |
| C | ASP167 |
| C | HOH402 |
| C | HOH418 |
| C | HOH501 |
| C | HOH523 |
| D | HIS170 |
| D | HOH425 |
Functional Information from PROSITE/UniProt
| site_id | PS00290 |
| Number of Residues | 7 |
| Details | IG_MHC Immunoglobulins and major histocompatibility complex proteins signature. YACEVTH |
| Chain | Residue | Details |
| A | TYR192-HIS198 | |
| B | TYR200-HIS206 |
